Free Trial

Short Interest in Spectral Medical Inc. (OTCMKTS:EDTXF) Declines By 23.0%

Spectral Medical logo with Medical background

Spectral Medical Inc. (OTCMKTS:EDTXF - Get Free Report) was the target of a significant drop in short interest during the month of November. As of November 30th, there was short interest totalling 58,300 shares, a drop of 23.0% from the November 15th total of 75,700 shares. Based on an average daily volume of 11,900 shares, the days-to-cover ratio is presently 4.9 days.

Spectral Medical Stock Down 4.9 %

Shares of OTCMKTS:EDTXF traded down $0.02 during trading on Friday, reaching $0.35. The company's stock had a trading volume of 3,100 shares, compared to its average volume of 16,974. The firm's 50 day simple moving average is $0.41 and its two-hundred day simple moving average is $0.42. Spectral Medical has a 12 month low of $0.28 and a 12 month high of $0.55.

Spectral Medical Company Profile

(Get Free Report)

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Spectral Medical right now?

Before you consider Spectral Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.

While Spectral Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines